Europe Thyroid Ablation Devices Market - Industry Trends and Forecast to 2028

TABLE OF CONTENT

TABLE OF CONTENTS 1 INTRODUCTION 1.1 OBJECTIVES OF THE STUDY 1.2 MARKET DEFINITION 1.3 OVERVIEW OF EUROPE THYROID ABLATION DEVICES MARKET 1.4 LIMITATIONS 1.5 MARKETS COVERED 2 MARKET SEGMENTATION 2.1 MARKETS COVERED 2.2 GEOGRAPHICAL SCOPE 2.3 YEARS CONSIDERED FOR THE STUDY 2.4 CURRENCY AND PRICING 2.5 DBMR TRIPOD DATA VALIDATION MODEL 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 2.7 MULTIVARIATE MODELLING 2.8 DISEASE LIFELINE CURVE 2.9 DBMR MARKET POSITION GRID 2.10 MARKET END USER COVERAGE GRID 2.11 VENDOR SHARE ANALYSIS 2.12 SECONDARY SOURCES 2.13 ASSUMPTIONS 3 EXECUTIVE SUMMARY 4 NUMBER OF PROCEDURES (2019-2028) 5 EUROPE THYROID ABLATION DEVICES MARKET: REGULATORY FRAMEWORK 5.1 THE IRELAND REGULATORY SCENARIO FOR TREATING ABLATION DEVICES FOR THYROID CANCER TREATMENT 5.2 THE U.K. REGULATORY SCENARIO FOR THYROID ABLATION DEVICES 5.3 THE BRITISH THYROID ASSOCIATION HAS PUBLISHED SPECIFIC VITAL REGULATORY GUIDELINES IN 2014: 5.4 SNM PRACTICE GUIDELINE FOR THERAPY OF THYROID DISEASE WITH 131I 3.0: 5.5 SPAIN REGULATORY SCENARIO FOR THYROID ABLATION DEVICES 5.6 ITALY REGULATORY SCENARIO FOR THYROID ABLATION DEVICES 6 EPIDEMIOLOGY 7 MARKET OVERVIEW 7.1 DRIVERS 7.1.1 INCREASING PREVALENCE OF THYROID NODULES & CANCER 7.1.2 ADVANCEMENTS IN ABLATION TECHNIQUES 7.1.3 INCREASING INVESTMENT IN R&D BY MARKET PARTICIPANTS 7.1.4 AVAILABILITY OF REIMBURSEMENT FOR ABLATION PROCEDURE 7.1.5 INCREASING HEALTHCARE EXPENDITURE 7.2 RESTRAINTS 7.2.1 HIGH COST OF THYROID NODULES ABLATION PROCEDURES 7.2.2 SIDE EFFECTS RELATED TO ABLATION TREATMENT 7.2.3 AVAILABILITY OF ALTERNATIVES 7.2.4 LACK OF AWARENESS FOR THYROID NODULES AND CANCER 7.3 OPPORTUNITIES 7.3.1 INCREASING GERIATRIC POPULATION 7.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS 7.3.3 INCREASED DEMAND FOR NON-INVASIVE PROCEDURE 7.4 CHALLENGES 7.4.1 LACK OF SKILLED PROFESSIONALS 7.4.2 LONG APPROVAL TIME ASSOCIATED WITH PRODUCT LAUNCH 8 IMPACT OF COVID-19 ON THE EUROPE THYROID ABLATION DEVICES MARKET 8.1 IMPACT ON PRICE 8.2 MPACT ON DEMAND 8.3 IMPACT ON SUPPLY CHAIN 8.4 STRATEGIC DECISION BY MANUFACTURERS 8.5 CONCLUSION 9 EUROPE THYROID ABLATION DEVICES MARKET, BY DISEASE 9.1 OVERVIEW 9.2 BENIGN THYROID NODULES 9.3 THYROID CANCER 10 EUROPE THYROID ABLATION DEVICES MARKET, BY PRODUCT TYPE 10.1 OVERVIEW 10.2 THERMAL BASED DEVICES 10.2.1 RADIOFREQUENCY 10.2.1.1 TEMPERATURE CONTROLLED-RADIOFREQUENCY ABLATORS 10.2.1.2 FLUID COOLED-RADIOFREQUENCY ABLATORS 10.2.1.3 ROBOTIC CATHETER MANIPULATION SYSTEMS 10.2.2 LASER/LIGHT ABLATORS 10.2.2.1 EXCIMER LASER ABLATORS 10.2.2.2 COLD LASER ABLATORS 10.2.3 ULTRASOUND ABLATORS 10.2.3.1 ULTRASONIC SURGICAL ABLATION SYSTEMS 10.2.3.2 HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) ABLATORS 10.2.3.3 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY (ESWL) SYSTEMS 10.2.3.4 MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND (MRGFUS) ABLATORS 10.2.4 MICROWAVE ABLATORS 10.2.5 ELECTRICAL ABLATORS 10.2.5.1 IRREVERSIBLE ELECTROPORATION ABLATORS 10.2.5.2 OTHERS 10.2.6 OTHERS 10.3 NON-THERMAL BASED DEVICES 10.3.1 CRYOABLATION DEVICES 10.3.1.1 TISSUE CONTACT 10.3.1.2 TISSUE SPRAY 10.3.1.3 EPIDERMAL AND SUBCUTANEOUS CRYOABLATION DEVICES 10.3.2 OTHERS 11 EUROPE THYROID ABLATION DEVICES MARKET, BY TYPE 11.1 OVERVIEW 11.2 RADIOFREQUENCY ABLATION 11.3 LASER OR LIGHT ABLATION 11.4 ULTRASOUND ABLATION 11.5 CRYOABLATION 11.6 ELECTRICAL ABLATION 11.7 MICROWAVE ABLATION 11.8 HYDROTHERMAL ABLATION 11.9 OTHERS 12 EUROPE THYROID ABLATION DEVICES MARKET, BY MODALITY 12.1 OVERVIEW 12.2 FIXED 12.3 PORTABLE 12.4 STANDALONE 13 EUROPE THYROID ABLATION DEVICES MARKET, BY END USER 13.1 OVERVIEW 13.2 HOSPITALS & SURGICAL CENTERS 13.2.1 RADIOLOGIST 13.2.2 SURGEON 13.2.3 ENDOCRINOLOGIST 13.2.4 NUCLEAR MEDICINE 13.3 ONCOLOGY CENTERS 13.4 CLINICS 13.5 COMMUNITY HEALTHCARE 13.6 OTHERS 14 EUROPE THYROID ABLATION DEVICES MARKET, BY DISTRIBUTION CHANNEL 14.1 OVERVIEW 14.2 DIRECT TENDER 14.3 THIRD PARTY DISTRIBUTOR 15 EUROPE THYROID ABLATION DEVICES MARKET, BY GEOGRAPHY 15.1 EUROPE 15.1.1 GERMANY 15.1.2 U.K. 15.1.3 FRANCE 15.1.4 ITALY 15.1.5 SPAIN 15.1.6 SWITZERLAND 15.1.7 RUSSIA 15.1.8 NETHERLANDS 15.1.9 BELGIUM 15.1.10 TURKEY 15.1.11 AUSTRIA 15.1.12 POLAND 15.1.13 IRELAND 15.1.14 UKRAINE 15.1.15 REST OF EUROPE 16 EUROPE THYROID ABLATION DEVICES MARKET: COMPANY LANDSCAPE 16.1 COMPANY SHARE ANALYSIS: EUROPE 17 COMPANY PROFILE 17.1 TERUMO EUROPE NV (A SUBSIDIARY OF TERUMO CORPORATION) 17.1.1 COMPANY SNAPSHOT 17.1.2 REVENUE ANALYSIS 17.1.3 PRODUCT PORTFOLIO 17.1.4 RECENT DEVELOPMENT 17.2 BIOSENSE WEBSTER, INC. (A SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC.) 17.2.1 COMPANY SNAPSHOT 17.2.2 REVENUE ANALYSIS 17.2.3 PRODUCT PORTFOLIO 17.2.4 RECENT DEVELOPMENTS 17.3 SMITH & NEPHEW 17.3.1 COMPANY SNAPSHOT 17.3.2 REVENUE ANALYSIS 17.3.3 PRODUCT PORTFOLIO 17.3.4 RECENT DEVELOPMENT 17.4 BIOTRONIK SE & CO. KG 17.4.1 COMPANY SNAPSHOT 17.4.2 PRODUCT PORTFOLIO 17.4.3 RECENT DEVELOPMENTS 17.5 MEDTRONIC 17.5.1 COMPANY SNAPSHOT 17.5.2 REVENUE ANALYSIS 17.5.3 PRODUCT PORTFOLIO 17.5.4 RECENT DEVELOPMENTS 17.6 MERIT MEDICAL SYSTEMS 17.6.1 COMPANY SNAPSHOT 17.6.2 REVENUE ANALYSIS 17.6.3 PRODUCT PORTFOLIO 17.6.4 RECENT DEVELOPMENTS 17.7 KONINKLIJKE PHILIPS N.V. 17.7.1 COMPANY SNAPSHOT 17.7.2 REVENUE ANALYSIS 17.7.3 PRODUCT PORTFOLIO 17.7.4 RECENT DEVELOPMENT 17.8 INTEGRA LIFESCIENCES CORPORATION 17.8.1 COMPANY SNAPSHOT 17.8.2 REVENUE ANALYSIS 17.8.3 PRODUCT PORTFOLIO 17.8.4 RECENT DEVELOPMENTS 17.9 BOSTON SCIENTIFIC CORPORATION 17.9.1 COMPANY SNAPSHOT 17.9.2 REVENUE ANALYSIS 17.9.3 PRODUCT PORTFOLIO 17.9.4 RECENT DEVELOPMENTS 17.10 CONMED CORPORATION 17.10.1 COMPANY SNAPSHOT 17.10.2 REVENUE ANALYSIS 17.10.3 PRODUCT PORTFOLIO 17.10.4 RECENT DEVELOPMENTS 17.11 OLYMPUS CORPORATION 17.11.1 COMPANY SNAPSHOT 17.11.2 REVENUE ANALYSIS 17.11.3 PRODUCT PORTFOLIO 17.11.4 RECENT DEVELOPMENTS 17.12 CARL ZEISS MEDITECH AG 17.12.1 COMPANY SNAPSHOT 17.12.2 REVENUE ANALYSIS 17.12.3 PRODUCT PORTFOLIO 17.12.4 RECENT DEVELOPMENTS 17.13 ATRICURE, INC. 17.13.1 COMPANY SNAPSHOT 17.13.2 REVENUE ANALYSIS 17.13.3 PRODUCT PORTFOLIO 17.13.4 RECENT DEVELOPMENTS 17.14 BAYLIS MEDICL COMPANY, INC. 17.14.1 COMPANY SNAPSHOT 17.14.2 PRODUCT PORTFOLIO 17.14.3 RECENT DEVELOPMENTS 17.15 ANGIODYNAMICS 17.15.1 COMPANY SNAPSHOT 17.15.2 REVENUE ANALYSIS 17.15.3 PRODUCT PORTFOLIO 17.15.4 RECENT DEVELOPMENTS 17.16 CHONGQUING HAIFU MEDICAL TECHNOLOGY CO., LTD. 17.16.1 COMPANY SNAPSHOT 17.16.2 PRODUCT PORTFOLIO 17.16.3 RECENT DEVELOPMENTS 17.17 DIREXGROUP 17.17.1 COMPANY SNAPSHOT 17.17.2 PRODUCT PORTFOLIO 17.17.3 RECENT DEVELOPMENTS 17.18 ICECURE MEDICAL 17.18.1 COMPANY SNAPSHOT 17.18.2 REVENUE ANALYSIS 17.18.3 PRODUCT PORTFOLIO 17.18.4 RECENT DEVELOPMENTS 17.19 IMRICOR 17.19.1 COMPANY SNAPSHOT 17.19.2 REVENUE ANALYSIS 17.19.3 PRODUCT PORTFOLIO 17.19.4 RECENT DEVELOPMENT 17.20 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD. 17.20.1 COMPANY SNAPSHOT 17.20.2 REVENUE ANALYSIS 17.20.3 PRODUCT PORTFOLIO 17.20.4 RECENT DEVELOPMENTS 17.21 MECHAN EUROPE LTD 17.21.1 COMPANY SNAPSHOT 17.21.2 PRODUCT PORTFOLIO 17.21.3 RECENT DEVELOPMENTS 17.22 STRYKER 17.22.1 COMPANY SNAPSHOT 17.22.2 REVENUE ANALYSIS 17.22.3 PRODUCT PORTFOLIO 17.22.4 RECENT DEVELOPMENTS 17.23 SONACARE MEDICAL 17.23.1 COMPANY SNAPSHOT 17.23.2 PRODUCT PORTFOLIO 17.23.3 RECENT DEVELOPMENTS 17.24 THERACLION 17.24.1 COMPANY SNAPSHOT 17.24.2 REVENUE ANALYSIS 17.24.3 PRODUCT PORTFOLIO 17.24.4 RECENT DEVELOPMENTS 17.25 TROD MEDICAL 17.25.1 COMPANY SNAPSHOT 17.25.2 PRODUCT PORTFOLIO 17.25.3 RECENT DEVELOPMENTS 18 SWOT 19 QUESTIONNAIRE 20 RELATED REPORTS